Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 7Phase 1 3Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 76Colorectal Neoplasms 55Carcinoma, Hepatocellular 51Stomach Neoplasms 34Colonic Neoplasms 26Breast Neoplasms 23Lung Neoplasms 15Rectal Neoplasms 12Ovarian Neoplasms 12Liver Neoplasms 12Sarcoma 11Gastrointestinal Neoplasms 11Neoplasms 10Esophageal Neoplasms 10Barrett Esophagus 9Melanoma 7Head and Neck Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Prostatic Neoplasms 6Cholangiocarcinoma 6Carcinoma, Renal Cell 5Neoplasm Metastasis 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Ductal Adenocarcinoma 3Osteosarcoma 3Esophageal Squamous Cell Carcinoma 3Disease 3Digestive System Neoplasms 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Gastric Adenocarcinoma × Gastrointestinal × Clear all
NCT07034742 2025-06-24

Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase EARLY_PHASE1 Recruiting
136 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡